Boulder, CO, United States of America

Hong-Woon Yang

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 153(Granted Patents)


Location History:

  • Superior, CO (US) (2012 - 2017)
  • Potomac, MD (US) (2015 - 2017)
  • Boulder, CO (US) (2012 - 2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: An Insight into the Innovations of Inventor Hong-Woon Yang

Introduction

Hong-Woon Yang, a prominent inventor based in Boulder, CO, has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on macrocyclic compounds and their applications in treating various diseases, including pain, cancer, and neurodegenerative disorders.

Latest Patents

Among Hong-Woon Yang's latest patents are two notable innovations titled "Macrocyclic compounds as TRK kinase inhibitors - Compounds of Formula I." These compounds and their pharmaceutically acceptable salts serve as inhibitors of Trk kinases, showing promise in the treatment of multiple medical conditions such as pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases. These inventions underscore his dedication to advancing therapeutic solutions through innovative chemical compounds.

Career Highlights

Throughout his career, Hong-Woon Yang has worked with esteemed organizations like Array Biopharma Inc. and Ventirx Pharmaceuticals, Inc. These experiences have contributed to his expertise and success as an inventor. His skills in the field of drug development and his understanding of molecular interactions have played a crucial role in his patent achievements.

Collaborations

Collaboration has been a key element of Hong-Woon Yang's career. He has partnered with talented professionals such as Jeongbeob Seo and Steven Wade Andrews. These collaborations have not only enriched his research but have also helped advance their shared goals of discovering innovative solutions in medicine.

Conclusion

In summary, Hong-Woon Yang stands out as a notable inventor in the pharmaceutical field, with a strong background and a dynamic portfolio of patents. His recent innovations in TRK kinase inhibitors highlight his commitment to improving healthcare outcomes through scientific advancements. As he continues to collaborate with other specialized professionals, the potential for future breakthroughs remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…